Safety and Preliminary Efficacy of Sequential Multiple Ascending Doses of Solnatide to Treat Pulmonary Permeability Oedema in Patients With Moderate-to-severe ARDS
Phase 2
Completed
- Conditions
- ARDS
- Interventions
- Drug: 0.9% Saline Solution
- First Posted Date
- 2018-06-26
- Last Posted Date
- 2025-05-14
- Lead Sponsor
- Apeptico Forschung und Entwicklung GmbH
- Target Recruit Count
- 92
- Registration Number
- NCT03567577
- Locations
- 🇦🇹
Univ.-klinik f. Herz-, Thorax-, Gefäßchirurgische Anästhesiologie und lntensivmedizin, Medizinische Universität Graz, Graz, Steiermark, Austria
🇦🇹Univ. Klinik für Innere Medizin / Gem. Einrichtung für Intensiv- und Notfallmedizin/GE Medizinische Universität Innsbruck, Innsbruck, Austria
🇦🇹Department of Anesthesia, General Intensive Care and Pain Control,Medical University of Vienna, Vienna, Austria
Study in Intensive Care Patients Regarding the Effect of Inhaled AP-301 After Primary Graft Dysfunction After Lung Transplantation
Phase 2
Completed
- Conditions
- PGD Primary Graft Dysfunction
- Interventions
- Drug: saline solution
- First Posted Date
- 2014-03-26
- Last Posted Date
- 2019-11-18
- Lead Sponsor
- Apeptico Forschung und Entwicklung GmbH
- Target Recruit Count
- 20
- Registration Number
- NCT02095626
- Locations
- 🇦🇹
Division of Thoracic Surgery MedUni Vienna, Vienna, Austria
Study in Intensive Care Patients to Investigate the Clinical Effect of Repetitive Orally Inhaled Doses of AP301 on Alveolar Liquid Clearance in Acute Lung Injury
- First Posted Date
- 2012-06-26
- Last Posted Date
- 2019-11-18
- Lead Sponsor
- Apeptico Forschung und Entwicklung GmbH
- Target Recruit Count
- 40
- Registration Number
- NCT01627613
- Locations
- 🇦🇹
Department of Anesthesia, General Intensive Care and Pain Control,Medical University of Vienna, Vienna, Austria
© Copyright 2025. All Rights Reserved by MedPath